Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00475982 · ClinicalTrials.gov registry record · NA
Effect of Weight Loss on Prostate Cancer Pathology
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT00475982: Completed NA study, sponsored by VA Office of Research and Development.
NCT00475982 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00475982, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if weight loss prior to radical prostatectomy effects chemical substances in the blood stream and prostate tissue that may affect prostate cancer development and progression.
Interventions
- BEHAVIORAL Weight Loss
- OTHER No Weight Loss Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2009-01 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00475982
The ClinicalTrials.gov registry entry for NCT00475982 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Weight Loss is the first listed.
NCT00475982 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00475982 about?
NCT00475982 is a clinical study titled "Effect of Weight Loss on Prostate Cancer Pathology". The purpose of this study is to determine if weight loss prior to radical prostatectomy effects chemical substances in the blood stream and prostate tissue that may affect prostate cancer development and progression.
What is the current status of trial NCT00475982?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2009-01. Estimated completion is 2016-03.
What interventions are being tested in trial NCT00475982?
The interventions under investigation include: Weight Loss (BEHAVIORAL), No Weight Loss Group (OTHER).
Who is sponsoring clinical trial NCT00475982?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.